[
Akeso's Penpulimab Receives NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer
[og_img]
https://www.investing.com/news/press-releases/akesos-penpulimab-receives-nmpa-approval-for-firstline-treatment-of-nasopharyngeal-cancer-93CH-3931034
Investing.com
Akeso's Penpulimab Receives NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer
Related articles